The Global Importance of Infectious Diseases | 传染病在全球范围内的重要性

📚 The Global Importance of Infectious Diseases | 传染病在全球范围内的重要性

Infectious diseases remain one of the most significant threats to global public health, causing millions of deaths each year and imposing enormous economic and social burdens worldwide. Understanding the global importance of infectious diseases is not merely an academic exercise—it is essential for developing effective prevention strategies, allocating resources wisely, and protecting vulnerable populations.

传染病仍然是全球公共卫生面临的最重大威胁之一，每年导致数百万人死亡，并在全球范围内造成巨大的经济和社会负担。理解传染病在全球范围内的重要性不仅仅是一项学术任务——它对于制定有效的预防策略、合理分配资源以及保护弱势群体至关重要。

1. The Nature of Infectious Diseases | 传染病的本质

Infectious diseases are disorders caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can be spread directly or indirectly from one individual to another. These diseases range from common infections like influenza to emerging epidemics such as COVID-19, and they account for approximately 15 million deaths globally each year—nearly one-quarter of all annual deaths worldwide.

传染病是由细菌、病毒、寄生虫或真菌等病原微生物引起的疾病，可以通过直接或间接方式在个体之间传播。这些疾病范围从流感等常见感染到新冠肺炎等新发流行病，每年在全球造成约1500万人死亡——占全球年死亡总数的近四分之一。

Key characteristics that determine the global impact of an infectious disease include:

Transmissibility (R₀): The basic reproduction number indicates how many people one infected individual can infect in a susceptible population.
传染性（R₀）： 基本再生数表示在易感人群中，一个感染者平均能传染给多少人。
Virulence: The severity of disease caused by the pathogen affects mortality rates and healthcare demand.
毒力： 病原体引起疾病的严重程度影响死亡率和医疗需求。
Incubation period: The time between infection and symptom onset influences how easily the disease spreads undetected.
潜伏期： 从感染到症状出现之间的时间影响疾病未被察觉传播的容易程度。

2. Modes of Transmission | 传播方式

Understanding how infectious diseases spread is fundamental to controlling them. Pathogens can be transmitted through multiple routes, and each route presents distinct challenges for global prevention efforts.

理解传染病如何传播是控制它们的基础。病原体可以通过多种途径传播，每种途径对全球预防工作都提出了不同的挑战。

The four principal modes of transmission are:

四种主要传播方式为：

Direct contact transmission: Physical contact between an infected person and a susceptible host, including touching, kissing, and sexual contact.
直接接触传播： 感染者与易感宿主之间的身体接触，包括触摸、亲吻和性接触。
Indirect contact transmission: Contact with contaminated fomites—objects or surfaces that harbour pathogens.
间接接触传播： 接触被污染的物体表面——即携带病原体的物品或表面。
Droplet transmission: Respiratory droplets expelled through coughing, sneezing, or talking can carry pathogens over short distances (typically under 1 metre).
飞沫传播： 通过咳嗽、打喷嚏或说话排出的呼吸道飞沫可在短距离内（通常不超过1米）携带病原体。
Airborne transmission: Tiny aerosol particles can remain suspended in air for extended periods and travel long distances.
空气传播： 微小的气溶胶颗粒可在空气中长时间悬浮并可传播较远距离。

Additionally, vector-borne transmission involves arthropods such as mosquitoes, ticks, and fleas carrying pathogens between hosts. Diseases like malaria, dengue fever, and Zika virus exemplify this route, and their global distribution is heavily influenced by climate and geography.

此外，媒介传播涉及蚊子、蜱虫和跳蚤等节肢动物在宿主之间携带病原体。疟疾、登革热和寨卡病毒等疾病是这一途径的典型例子，其全球分布深受气候和地理的影响。

3. Global Burden of Disease | 全球疾病负担

The global burden of infectious diseases is measured not only in mortality but also in disability-adjusted life years (DALYs), which combine years of life lost due to premature death with years lived with disability. This metric provides a more complete picture of the true impact of infectious diseases on human populations.

传染病的全球负担不仅通过死亡率来衡量，还通过伤残调整生命年（DALYs）来衡量，后者将过早死亡导致的寿命损失年数与带病生存的年数相结合。这一指标更全面地反映了传染病对人类群体的真实影响。

Disease	Annual Deaths (approximate)	Main Affected Regions
Lower respiratory infections	2.6 million	Global, especially children under 5
Tuberculosis	1.3 million	Sub-Saharan Africa, South-East Asia
Malaria	620,000	Sub-Saharan Africa
HIV/AIDS	680,000	Sub-Saharan Africa, Asia
Diarrhoeal diseases	1.5 million	Low-income countries

Children under five years of age bear a disproportionate share of this burden, with infectious diseases accounting for more than 40% of deaths in this age group. Notably, the vast majority of these deaths occur in low- and middle-income countries, highlighting profound global health inequities.

五岁以下儿童承担的负担不成比例地沉重，传染病占该年龄段死亡人数的40%以上。值得注意的是，这些死亡绝大多数发生在低收入和中等收入国家，凸显了深刻的全球健康不平等问题。

4. Socioeconomic Impact | 社会经济影响

Infectious diseases exert a profound socioeconomic toll. They perpetuate poverty cycles by reducing workforce productivity, increasing healthcare expenditures, and diverting resources from education and infrastructure development. The World Bank estimates that major epidemics can reduce a country’s GDP by 1–5% annually.

传染病造成了深远的社经损失。它们通过降低劳动力生产率、增加医疗支出，以及将资源从教育和基础设施发展中转移出去，使贫困循环持续下去。世界银行估计，重大流行病可使一个国家的GDP每年减少1%至5%。

The economic consequences operate at multiple levels:

经济后果体现在多个层面：

Individual level: Loss of income due to illness, out-of-pocket medical expenses, and caring for sick family members can push households into poverty.
个人层面： 因病导致的收入损失、自付医疗费用以及照顾生病家庭成员的开支会使家庭陷入贫困。
Community level: Outbreaks disrupt local businesses, schools, and essential services such as transport and food distribution.
社区层面： 疫情暴发会扰乱当地商业、学校以及交通和食品分配等基本服务。
National/global level: International trade restrictions, reduced tourism, and diverted healthcare resources affect entire economies. The COVID-19 pandemic, for instance, caused the most severe global economic recession since the Great Depression.
国家/全球层面： 国际贸易限制、旅游业减少和医疗资源转移影响整个经济体。例如，COVID-19大流行导致了自大萧条以来最严重的全球经济衰退。

5. Factors Contributing to Global Spread | 促进全球传播的因素

Several interconnected factors facilitate the rapid global spread of infectious diseases in the modern era, making containment increasingly challenging.

在当今时代，若干相互关联的因素助长了传染病在全球范围内的快速传播，使得防控变得越来越具有挑战性。

Key contributing factors include:

关键促进因素包括：

Global travel and trade: Over 4 billion airline passengers travel annually, allowing pathogens to cross continents within hours—far shorter than most incubation periods.
全球旅行和贸易： 每年有超过40亿航空旅客出行，使病原体能在数小时内跨越各大洲——远短于大多数潜伏期。
Urbanisation: High population density in cities creates ideal conditions for person-to-person transmission. By 2050, nearly 70% of the world population is projected to live in urban areas.
城市化： 城市中高人口密度为人际传播创造了理想条件。预计到2050年，全球近70%的人口将居住在城市地区。
Climate change: Rising temperatures expand the geographical range of disease vectors such as mosquitoes, exposing new populations to vector-borne diseases.
气候变化： 气温升高扩大了蚊子等疾病媒介的地理分布范围，使新的人群暴露于媒介传播疾病。
Deforestation and land use change: Habitat destruction brings humans into closer contact with wildlife, increasing the risk of zoonotic spillover events.
森林砍伐和土地利用变化： 栖息地破坏使人类与野生动物更近距离接触，增加了人畜共患病溢出事件的风险。
Antimicrobial resistance: Misuse and overuse of antibiotics have accelerated the evolution of drug-resistant pathogens, threatening our ability to treat common infections.
抗菌药耐药性： 抗生素的误用和过度使用加速了耐药病原体的演化，威胁到我们治疗常见感染的能力。

6. Antimicrobial Resistance | 抗菌药耐药性

Antimicrobial resistance (AMR) represents one of the gravest threats to global health, potentially undermining a century of medical progress. It occurs when microorganisms evolve mechanisms to survive exposure to drugs that previously killed them or inhibited their growth. This is a natural evolutionary process, but it has been dramatically accelerated by human activities.

抗菌药耐药性（AMR）是对全球健康最严重的威胁之一，可能破坏一个世纪以来的医学进步。当微生物演化出在先前能杀死或抑制其生长的药物面前存活的能力时，耐药性便出现了。这是一个自然演化过程，但人类活动已极大地加速了它。

Critical factors driving AMR include:

推动抗菌药耐药性的关键因素包括：

Overprescription: Antibiotics are frequently prescribed for viral infections where they are ineffective.
过度处方： 抗生素经常被开给对其无效的病毒感染。
Agricultural use: Approximately 70% of global antibiotic use occurs in livestock farming, often for growth promotion rather than disease treatment.
农业用途： 全球约70%的抗生素使用发生在畜牧业中，通常用于促进生长而非治疗疾病。
Poor infection control: Inadequate hygiene and sterilisation practices in healthcare settings facilitate the spread of resistant strains.
感染控制不力： 医疗机构中卫生和灭菌操作不规范助长了耐药菌株的传播。

Resistance develops through several biological mechanisms, including:

耐药性通过几种生物学机制产生，包括：

Plasmid transfer (horizontal gene transfer) → spread of resistance genes between bacterial species

质粒转移（水平基因转移）→ 耐药基因在不同细菌物种之间传播

The WHO has declared AMR one of the top 10 global public health threats facing humanity, with projections suggesting drug-resistant infections could cause 10 million deaths annually by 2050 if no urgent action is taken.

世界卫生组织已将抗菌药耐药性列为人类面临的十大全球公共卫生威胁之一，预测如果不采取紧急行动，到2050年耐药感染每年可能导致1000万人死亡。

7. Global Surveillance and Response | 全球监测与应对

Effective global response to infectious diseases relies on robust surveillance systems that detect outbreaks early and enable rapid coordinated action. The International Health Regulations (IHR), legally binding for 196 countries, establish the framework for global health security.

有效应对传染病依赖于强大的监测系统，这些系统能够及早发现疫情并促成快速协调行动。《国际卫生条例》（IHR）对196个国家具有法律约束力，建立了全球卫生安全的框架。

Key components of effective surveillance include:

有效监测的关键组成部分包括：

Real-time reporting: Countries are required to report certain disease outbreaks to WHO within 24 hours of detection.
实时报告： 各国有义务在发现某些疾病疫情后24小时内向世界卫生组织报告。
Genomic surveillance: Whole-genome sequencing allows scientists to track pathogen evolution, identify new variants, and trace transmission chains.
基因组监测： 全基因组测序使科学家能够追踪病原体演化、识别新变体并追溯传播链。
Wastewater monitoring: Testing sewage samples can provide early warning of disease circulation in communities, including asymptomatic cases.
废水监测： 检测污水样本可以及早预警疾病在社区中的传播情况，包括无症状病例。

Rapid response mechanisms include contact tracing, quarantine protocols, travel restrictions, and the rapid deployment of medical countermeasures. The COVID-19 pandemic demonstrated both the power of global scientific collaboration—with vaccines developed in under 12 months—and the consequences of inequitable vaccine distribution.

快速响应机制包括接触者追踪、检疫方案、旅行限制以及医疗对策的快速部署。COVID-19大流行既展示了全球科学合作的力量——疫苗在不到12个月内被开发出来——也展示了疫苗分配不公平的后果。

8. Vaccination and Herd Immunity | 疫苗接种与群体免疫

Vaccination remains the most effective tool for preventing infectious diseases. By stimulating the immune system to produce memory cells without causing disease, vaccines provide long-lasting protection and, when coverage is sufficiently high, confer herd immunity that protects vulnerable individuals who cannot be vaccinated.

疫苗接种仍然是预防传染病最有效的工具。通过在不可起疾病的情况下刺激免疫系统产生记忆细胞，疫苗提供了长期保护，并且当接种覆盖率足够高时，能产生保护无法接种疫苗的弱势个体的群体免疫。

Herd immunity threshold depends on the basic reproduction number (R₀):

群体免疫阈值取决于基本再生数（R₀）：

Herd immunity threshold = 1 − (1/R₀) × 100%

群体免疫阈值 = 1 − (1/R₀) × 100%

For measles with R₀ = 12–18, approximately 92–95% vaccination coverage is required. For polio with R₀ = 5–7, approximately 80–85% coverage suffices. Smallpox, the only infectious disease ever eradicated, had R₀ = 5–7 and was eliminated through a global vaccination campaign completed in 1980.

对于R₀ = 12–18的麻疹，需要约92%至95%的疫苗接种覆盖率。对于R₀ = 5–7的脊髓灰质炎，约80%至85%的覆盖率就足够。天花是有史以来唯一被根除的传染病，其R₀ = 5–7，通过1980年完成的全球疫苗接种运动被消灭。

Vaccination programmes save an estimated 2–3 million lives annually. However, vaccine hesitancy—driven by misinformation, complacency, and lack of confidence—threatens to reverse decades of progress. The WHO identifies vaccine hesitancy as one of the top ten threats to global health.

疫苗接种计划每年估计挽救200万至300万人的生命。然而，由错误信息、自满情绪和信心不足驱动的疫苗犹豫，正威胁着逆转几十年的进步。世界卫生组织将疫苗犹豫列为全球健康面临的十大威胁之一。

9. Emerging and Re-emerging Diseases | 新发与再发传染病

The past few decades have witnessed an alarming increase in emerging infectious diseases—conditions that have newly appeared in human populations or that existed but are rapidly increasing in incidence or geographical range. Approximately 75% of emerging infectious diseases are zoonotic in origin.

过去几十年，新发传染病的数量出现了令人警惕的增长——这些疾病新近出现在人类群体中，或先前已存在但发病率或地理分布范围正在迅速扩大。约75%的新发传染病源于人畜共患病。

Notable examples include:

值得注意的例子包括：

COVID-19 (2019): Caused by SARS-CoV-2, likely originating from bats, spread globally within months.
COVID-19（2019年）： 由SARS-CoV-2引起，可能源于蝙蝠，在数月内传播至全球。
Ebola virus disease: Periodic outbreaks in West Africa with fatality rates up to 90% in some outbreaks.
埃博拉病毒病： 在西非周期性暴发，某些疫情中病死率高达90%。
Zika virus: Spread by Aedes mosquitoes; caused microcephaly outbreaks in Brazil in 2015–2016.
寨卡病毒： 由伊蚊传播；2015至2016年在巴西引起了小头症疫情。
Nipah virus: Fruit bats are the natural host; person-to-person transmission occurs in healthcare settings.
尼帕病毒： 果蝠是天然宿主；在医疗环境中发生人际传播。

Re-emerging diseases such as tuberculosis, cholera, and yellow fever are resurging in regions where they were previously controlled, often due to conflict, weak health systems, or antimicrobial resistance. In 2020, TB notification dropped sharply in many countries due to COVID-19 disruptions, allowing undetected community transmission to continue.

结核病、霍乱和黄热病等再发传染病此前已得到控制的地区重新抬头，通常是由于冲突、卫生系统薄弱或抗菌药耐药性所致。2020年，许多国家因COVID-19干扰而结核病报告数急剧下降，使未被发现的社区传播持续进行。

10. Global Cooperation and Health Equity | 全球合作与健康公平

Infectious diseases do not respect national borders, making international cooperation essential. The concept of global health security recognises that a health threat anywhere is a threat everywhere. However, the global response has often been hampered by inequities in resources, technology, and political will.

传染病不分国界，因此国际合作必不可少。全球卫生安全的概念认识到，任何地方的健康威胁都是对所有人的威胁。然而，全球应对往往受到资源、技术和政治意愿不平等的阻碍。

Critical areas for global cooperation include:

全球合作的关键领域包括：

Vaccine equity: During the COVID-19 pandemic, high-income countries vaccinated their populations rapidly while many lower-income countries waited months or years. By late 2021, less than 5% of people in low-income countries had received at least one vaccine dose, compared to 70% in high-income countries.
疫苗公平： 在COVID-19大流行期间，高收入国家迅速为其人口接种疫苗，而许多低收入国家等待了数月甚至数年。截至2021年底，低收入国家中只有不到5%的人接种了至少一剂疫苗，而高收入国家为70%。
Capacity building: Strengthening local healthcare infrastructure and surveillance capabilities in resource-limited settings prevents outbreaks at the source.
能力建设： 在资源有限的地区加强当地医疗基础设施和监测能力，可在源头预防疫情。
COVAX and similar mechanisms: Initiatives designed to accelerate equitable access to vaccines and medicines.
COVAX及类似机制： 旨在加速疫苗和药物公平获取的倡议。
One Health approach: Recognising the interconnection between human health, animal health, and environmental health is crucial for preventing zoonotic diseases and addressing AMR.
同一健康方法： 认识到人类健康、动物健康和环境健康之间的相互联系，对于预防人畜共患疾病和应对抗菌药耐药性至关重要。

11. The Impact of Climate Change on Infectious Diseases | 气候变化对传染病的影响

Climate change is acting as a threat multiplier for infectious diseases, altering the geographical distribution and seasonality of many pathogens and their vectors. Rising global temperatures, changing precipitation patterns, and more frequent extreme weather events create new opportunities for disease transmission.

气候变化正在成为传染病的威胁倍增器，改变着许多病原体及其媒介的地理分布和季节性。全球气温上升、降水模式变化以及更频繁的极端天气事件为疾病传播创造了新的机会。

Documented and projected effects include:

已记录和预测的影响包括：

Expansion of vector range: Anopheles mosquitoes transmitting malaria are expanding into higher altitudes and latitudes that were previously too cold. The Aedes mosquito vector for dengue is now present in Europe and parts of North America.
媒介分布范围扩大： 传播疟疾的按蚊正在向之前过于寒冷的高海拔和高纬度地区扩展开来。传播登革热的伊蚊现在已出现在欧洲和北美部分地区。
Extended transmission seasons: Warmer temperatures lengthen the periods during which vectors can survive and reproduce, extending disease transmission windows.
传播季节延长： 气温升高延长了媒介能够存活和繁殖的时间段，从而使疾病传播窗口延长。
Waterborne disease risk: Flooding events can overwhelm sanitation systems, leading to outbreaks of cholera, cryptosporidiosis, and leptospirosis.
水媒疾病风险： 洪水事件可使卫生系统不堪重负，导致霍乱、隐孢子虫病和钩端螺旋体病暴发。
Changes in host behaviour: Altered migration patterns of wild birds may affect the spread of avian influenza.
宿主行为改变： 野生鸟类迁徙模式的改变可能影响禽流感的传播。

By 2070, it is projected that over half of the world population could be exposed to dengue fever, compared to just half a billion people today. Climate change adds urgency to the need for climate-resilient health systems and integrated disease surveillance.

据预测，到2070年，全球可能有一半以上的人口面临登革热风险，而目前约只有5亿人。气候变化加大了建立气候适应性卫生系统和综合性疾病监测的紧迫性。

12. Future Directions and Conclusion | 未来方向与结论

The global importance of infectious diseases demands a comprehensive, forward-looking approach that addresses root causes while strengthening response capabilities. Lessons from past pandemics and ongoing outbreaks provide a roadmap for future preparedness.

传染病的全球重要性要求一种全面且具有前瞻性的方法，既要解决根本原因，又要加强应对能力。过去大流行和持续疫情的经验教训为未来的防范提供了路线图。

Priority actions for the future include:

未来的优先行动包括：

Strengthening universal health coverage: Ensuring all people can access essential health services without facing financial hardship.
加强全民健康覆盖： 确保所有人都能获得基本卫生服务而不面临经济困难。
Accelerating research and development: Investment in rapid diagnostic tests, next-generation vaccines, and novel antimicrobial therapies to counter AMR.
加速研发： 投资于快速诊断测试、下一代疫苗以及对抗抗菌药耐药性的新型抗菌疗法。
Integrating environmental and health policy: Addressing deforestation, biodiversity loss, and climate change as integral components of infectious disease prevention.
整合环境与卫生政策： 将森林砍伐、生物多样性丧失和气候变化作为传染病预防的组成部分加以解决。
Fostering community engagement: Building trust in health systems and public health messaging to counter misinformation and vaccine hesitancy.
促进社区参与： 建立对卫生系统和公共卫生信息传递的信任，以对抗错误信息和疫苗犹豫。

As the COVID-19 pandemic has demonstrated with devastating clarity, the world remains vulnerable to infectious diseases. Yet improved surveillance, global solidarity, scientific advancement, and political commitment can significantly reduce that vulnerability. For A-Level Biology students, understanding the global importance of infectious diseases is not just about memorising pathogens and transmission routes—it is about appreciating the complex interplay of biology, social systems, environment, and global policy that determines disease outcomes. The future of global health will depend on training a new generation who understands these connections and is equipped to address them.

正如COVID-19大流行以令人痛心的清晰度所展示的那样，世界仍然容易受到传染病的侵害。然而，改善监测、全球团结、科学进步和政治承诺可以显著降低这种脆弱性。对于A-Level生物学的学生来说，理解传染病全球重要性的意义不仅仅是记住病原体和传播途径——而是要理解生物学、社会系统、环境和全球政策之间决定疾病结局的复杂相互作用。全球健康的未来将取决于培养理解这些联系并有能力应对它们的新一代。

Published by TutorHao | Biology Revision Series | aleveler.com

更多咨询请联系16621398022（同微信）

The Global Importance of Infectious Diseases | 传染病在全球范围内的重要性